Ion Torrent ships three next-generation sequencers

Ion Torrent, a unit of Life Technologies Corporation (NASDAQ: LIFE), today announced that it is shipping its new 100 Mb Ion 316™ chip, which has tenfold more throughput than the original Ion 314™ chip, and that its 1 Gb Ion 318™ chip will be available in the fourth quarter. These three chips will deliver an unprecedented hundredfold increase in throughput in a single year, demonstrating the tremendous scalability of semiconductor sequencing.

Ion Torrent also announced that it has the fastest workflow in the industry, at under eight hours, a threefold improvement since the company's launch six months ago. Scientists have responded to these advances in sequencing speed, scalability and simplicity by making the Ion Personal Genome Machine™ system the fastest selling next-generation sequencer with placements in more than 40 countries.

"Semiconductor technology has transformed every industry it has touched, from computing to photography to music, and now it's transforming the life sciences," said Ion Torrent President and COO Gregg Fergus. "In just the six months since Ion Torrent launched the Ion Personal Genome Machine sequencer, we have made huge advances and that will continue in the second half of the year when we'll increase read lengths to 200 base pairs and throughput by another tenfold."

Value

The scalability of Ion semiconductor sequencing offers exceptional value as well as performance. The Ion 314™ chip is now available for just $99, which we believe will enable the sequencing community to develop novel methods and applications.  Ion is able to lower the price because of the significant sales volume generated by the Ion 314™ chip and the economies of scale inherent in semiconductor manufacturing. Additionally, each of the three new chips will work on the same Ion PGM™ sequencer, enabling users to buy only as much throughput as they need, from 10 Mb to 1 Gb.

Speed

The Ion Torrent single-day workflow -- from library preparation to data analysis -- is now the fastest in the next-generation sequencing industry, at eight to nine hours depending on the read length required. Ion has reduced the time by about threefold in just six months thanks to three key breakthroughs:

  1. The new Ion Xpress™ Fragment Library Kit, shipping this week, offers a novel enzymatic fragmentation process that has reduced the library preparation time to 3.5 hours, 60 percent faster than six months ago.
  2. The Ion OneTouch™ System for template preparation, shipping later this quarter, now features a new component to automate enrichment, the Ion OneTouch™ ES. The entire template preparation process is fully automated and can be completed in three hours, 70 percent faster than six months ago.
  3. Finally, the new Torrent Suite 1.4 analysis software has cut chip analysis time in half to 60 minutes for the Ion 316™ chip and just 30 minutes for the Ion 314™ chip, while also delivering a significant improvement in accuracy.

Accuracy

The Ion PGM™ system's accuracy has improved by an order of magnitude since it was launched six months ago. Ion Torrent has capitalized on the inherent accuracy of its simple sequencing chemistry, achieving more signal, better signal processing and improved base calling. Accuracy improved so rapidly in part because the Ion PGM™ sequencer's two-hour run times enabled Ion Torrent's R&D teams to quickly test and refine their ideas. Improvements in accuracy will help Ion Torrent reach 200 bp reads in the second half of this year and 400 bp reads in 2012.

More New Products

Additional new products now available include an early access version of the Ion DNA Barcoding 1-16 Kit for multiplexed sequencing analysis of up to 16 samples on a single chip which drastically reduces cost per sample and increases sample throughput. The Ion Library Quantitation Kit, a highly sensitive TaqMan®-based solution providing rapid and accurate femtomolar-level quantitation of Ion Torrent DNA libraries using qPCR, and the Ion Sphere™ Control Kit for template bead quality control using the Qubit® 2.0 Fluorometer also join the new product portfolio.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Extrachromosomal DNA in more aggressive cancers could be targets for future therapies